242 related articles for article (PubMed ID: 32873791)
1. Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak.
Dingens AS; Crawford KHD; Adler A; Steele SL; Lacombe K; Eguia R; Amanat F; Walls AC; Wolf CR; Murphy M; Pettie D; Carter L; Qin X; King NP; Veesler D; Krammer F; Dickerson JA; Chu HY; Englund JA; Bloom JD
Nat Commun; 2020 Sep; 11(1):4378. PubMed ID: 32873791
[TBL] [Abstract][Full Text] [Related]
2. Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak.
Dingens AS; Crawford KHD; Adler A; Steele SL; Lacombe K; Eguia R; Amanat F; Walls AC; Wolf CR; Murphy M; Pettie D; Carter L; Qin X; King NP; Veesler D; Krammer F; Dickerson JA; Chu HY; Englund JA; Bloom JD
medRxiv; 2020 Jun; ():. PubMed ID: 32511483
[TBL] [Abstract][Full Text] [Related]
3. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study.
Pallett SJC; Rayment M; Patel A; Fitzgerald-Smith SAM; Denny SJ; Charani E; Mai AL; Gilmour KC; Hatcher J; Scott C; Randell P; Mughal N; Jones R; Moore LSP; Davies GW
Lancet Respir Med; 2020 Sep; 8(9):885-894. PubMed ID: 32717210
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serologic and molecular SARS-CoV 2 results in a large cohort in Southern Tuscany demonstrates a role for serologic testing to increase diagnostic sensitivity.
Pancrazzi A; Magliocca P; Lorubbio M; Vaggelli G; Galano A; Mafucci M; Duranti D; Cortesi M; Mazzeschi E; Fabbroni S; Viti G; Tartaglia Polcini A; Tripodo E; Sanchini P; Gervino S; Tacconi D; Dei S; Mazzierli M; D'Urso A; Ognibene A
Clin Biochem; 2020 Oct; 84():87-92. PubMed ID: 32702365
[TBL] [Abstract][Full Text] [Related]
5. Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series.
Rizzoli L; Collini L; Magnano M; Termine S; Barcelli R; Infusino SD; Bauer P; Rech G; Girardelli CR; Balestri R
Br J Dermatol; 2020 Oct; 183(4):782-784. PubMed ID: 32613620
[No Abstract] [Full Text] [Related]
6. What to Expect from Antibody Assays of SARS-CoV-2?
Yi X; Cao J
J Appl Lab Med; 2020 Sep; 5(5):1126-1130. PubMed ID: 32589736
[No Abstract] [Full Text] [Related]
7. Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January-March 2020.
Rha B; Lively JY; Englund JA; Staat MA; Weinberg GA; Selvarangan R; Halasa NB; Williams JV; Boom JA; Sahni LC; Michaels MG; Stewart LS; Harrison CJ; Szilagyi PG; McNeal MM; Klein EJ; Strelitz B; Lacombe K; Schlaudecker E; Moffatt ME; Schuster JE; Pahud BA; Weddle G; Hickey RW; Avadhanula V; Wikswo ME; Hall AJ; Curns AT; Gerber SI; Langley G
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):609-612. PubMed ID: 32556327
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
[TBL] [Abstract][Full Text] [Related]
10. Changes in SARS-CoV-2 Positivity Rate in Outpatients in Seattle and Washington State, March 1-April 16, 2020.
Randhawa AK; Fisher LH; Greninger AL; Li SS; Andriesen J; Corey L; Jerome KR
JAMA; 2020 Jun; 323(22):2334-2336. PubMed ID: 32383728
[TBL] [Abstract][Full Text] [Related]
11. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
[TBL] [Abstract][Full Text] [Related]
12. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test.
Meschi S; Colavita F; Bordi L; Matusali G; Lapa D; Amendola A; Vairo F; Ippolito G; Capobianchi MR; Castilletti C;
J Clin Virol; 2020 Aug; 129():104539. PubMed ID: 32679298
[TBL] [Abstract][Full Text] [Related]
13. The role of serological testing in the SARS-CoV-2 outbreak.
Mayne ES; Scott L; Semete B; Julsing A; Jugwanth S; Mampeule N; David A; Gededzha MP; Goga A; Hardie D; Preiser W; Chetty K; Rees H; Sanne I; Mlisana K; George JA; Stevens W
S Afr Med J; 2020 Jul; 110(9):842-845. PubMed ID: 32880264
[TBL] [Abstract][Full Text] [Related]
14. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
[TBL] [Abstract][Full Text] [Related]
15. All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions.
Denina M; Pellegrino F; Morotti F; Coppo P; Bonsignori IM; Garazzino S; Ravanini P; Avolio M; Cavallo R; Bertolotti L; Felici E; Acucella G; Montin D; Rabbone I; Licciardi F
J Am Acad Dermatol; 2020 Dec; 83(6):1751-1753. PubMed ID: 32781180
[No Abstract] [Full Text] [Related]
16. Parental Coronavirus Disease 2019 Testing of Hospitalized Children: Rethinking Infection Control in a Pandemic.
Hassoun A; Prasad N; Pugh S; Merced I; Abularrage J; Sharma M
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):564-565. PubMed ID: 32856705
[TBL] [Abstract][Full Text] [Related]
17. Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument.
Wu AHB
J Appl Lab Med; 2020 Sep; 5(5):1107-1110. PubMed ID: 32609341
[No Abstract] [Full Text] [Related]
18. The Light and Shadow of Rapid Serological Tests for SARS-CoV-2 Infection: Results from a Study in a Large Emergency Department.
Loconsole D; Centrone F; Morcavallo C; Campanella S; Sallustio A; Quarto M; Procacci V; Chironna M
Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32906596
[TBL] [Abstract][Full Text] [Related]
19. Is Nasopharyngeal Swab Comparable With Nasopharyngeal Aspirate to Detect SARS-CoV-2 in Children?
Capecchi E; Di Pietro GM; Luconi E;
Pediatr Infect Dis J; 2020 Sep; 39(9):e288-e289. PubMed ID: 32740453
[No Abstract] [Full Text] [Related]
20. Clinical Performance of SARS-CoV-2 Molecular Tests.
Green DA; Zucker J; Westblade LF; Whittier S; Rennert H; Velu P; Craney A; Cushing M; Liu D; Sobieszczyk ME; Boehme AK; Sepulveda JL
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32513858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
